Developmental Origins of Kidney Function in Early Life and Environmental Risks

生命早期肾功能的发育起源和环境风险

基本信息

项目摘要

Project Summary NYU School of Medicine, Rush University Medical Center and New York State Department of Health respond to PA-19-056, proposing to study developmental origins of kidney function in early life and environmental risks. The incidence of chronic kidney disease (CKD) is steadily rising and synthetic chemicals are increasingly understood to contribute to acute and chronic kidney injury. Case-control studies of populations with high incidence rates have identified pesticide and herbicide exposures as risks, raising the question whether developmental exposures may be even more impactful. Our own studies of children with CKD (R01DK100307) have revealed modest declines in kidney function with increasing phthalate and bisphenol exposures, accompanied by increases in oxidative stress. However, these findings do not contribute to our understanding of the origin of CKD. A major limitation is the failure of our and other studies to account for the developmental biology of the kidney and strong influence of perinatal/infant factors. The premise of the present proposal is that intrauterine inflammatory processes disrupt nephrogenesis and that environmental chemicals also impair renal parenchymal growth longitudinally during gestation and postnatal development via oxidant stress. We further interrogate this hypothesis by examining phthalates, bisphenols, glyphosate and organophosphate (OP) pesticides as modifiable risks. We will test these hypotheses in the New York University Children's Health and Environment Study, one of the participating cohorts in the NIH Environmental Influences and Child Health Outcomes Program (UH3OD023305). The proposed work builds upon our experience with postnatal renal sonographic measurement, which we will add prospectively to the existing, funded follow up. The approach is cost-efficient, leveraging existing measures for three exposure categories in pregnancy and infancy and available biospecimens to measure soluble urokinase-type plasminogen activator receptor, an emerging marker of kidney injury and development, and glyphosate. The MPIs (Trasande and Trachtman) are highly complementary, coupling experts in children's environmental health with nephrology who have a track record of productive MPI partnership in R01DK100307, which produced preliminary data in support of the proposed work. Analyses will be performed by K. Kannan at Wadsworth Laboratories of the New York State Department of Health, who has deep experience with precise measurement of glyphosate and metabolites in urine. In contrast to many known CKD risks which are not amenable to modification or avoidance, pesticides and herbicides can be reduced by consuming organic foods while phthalates and bisphenols can be reduced by avoiding canned and processed foods. The proposed work has the potential to shift the paradigm of origins of CKD to focus needed attention on its developmental origins.
项目摘要 纽约大学医学院,拉什大学医学中心和纽约州卫生部响应 到PA-19-056,提议研究早期生活和环境风险中肾脏功能的发育起源。 慢性肾脏疾病(CKD)的发生率稳步上升,合成化学物质越来越多 据了解会导致急性和慢性肾脏损伤。病例对照研究高 发病率已经确定农药和除草剂的暴露是风险,提出了一个问题 发展暴露可能更具影响力。我们对CKD儿童的研究(R01DK100307) 揭示了肾脏功能的适度下降,邻苯二甲酸盐和双酚暴露量增加, 伴随着氧化应激的增加。但是,这些发现并不有助于我们的理解 CKD的起源。一个主要限制是我们和其他研究未能解释发展 肾脏的生物学和围产期/婴儿因素的强大影响。本提议的前提是 宫内炎症过程破坏了肾病,环境化学物质也损害了 肾实质生长在妊娠和产后发育过程中通过氧化剂应激进行纵向生长。我们 通过检查邻苯二甲酸,双苯酚,草甘膦和有机磷酸盐(OP)来进一步询问这一假设。 农药是可修改的风险。我们将在纽约大学儿童健康中检验这些假设 环境研究,NIH环境影响和儿童健康的参与人群之一 结果程序(UH3OD023305)。拟议的工作以我们在产后肾脏的经验为基础 超声测量,我们将前瞻性地添加到现有的资助后续行动中。方法是 成本效益,利用怀孕和婴儿期三个暴露类别的现有措施, 可用的生物测量来测量可溶性尿激酶型纤溶酶原激活剂受体,一种出现的 肾脏损伤和发育的标记以及草甘膦。 MPI(Trasande和Trachtman)很高 具有往绩记录的儿童环境健康的互补,耦合专家 R01DK100307的生产MPI合作伙伴关系,该合作生成了初步数据以支持拟议的 工作。分析将由纽约州沃兹沃思实验室的K. Kannan进行 健康,他在尿液中精确测量草甘膦和代谢物方面具有深厚的经验。在 与许多已知的CKD风险形成对比,这些风险不适合修改或避免,农药和 除草剂可以通过食用有机食品而减少,而邻苯二甲酸盐和双酚可以通过 避免罐头和加工食品。拟议的工作有可能改变 CKD要集中精力需要关注其发展起源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOWARD TRACHTMAN其他文献

HOWARD TRACHTMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOWARD TRACHTMAN', 18)}}的其他基金

Environmental Oxidant Stressors in Pediatric Chronic Kidney Disease - Resubmissio
小儿慢性肾脏病中的环境氧化应激 - Resubmissio
  • 批准号:
    8911312
  • 财政年份:
    2014
  • 资助金额:
    $ 72.04万
  • 项目类别:
CLINICAL TRIAL: TREATMENT WITH (F6-3019) FOR FOCAL GLOMERULOSCLEROSIS
临床试验:(F6-3019)治疗局灶性肾小球硬化症
  • 批准号:
    7951946
  • 财政年份:
    2009
  • 资助金额:
    $ 72.04万
  • 项目类别:
TREATMENT WITH HUMAN MONOCLONAL ANTIBODY TO CONNECTIVE TISSUE GROWTH FACTOR (FG-
结缔组织生长因子 (FG-) 人单克隆抗体治疗
  • 批准号:
    7719299
  • 财政年份:
    2008
  • 资助金额:
    $ 72.04万
  • 项目类别:
CATHETER-RELATED INFECTIONS IN PEDIATRIC DIALYSIS PATIENTS: POTENTIAL ROLE OF
小儿透析患者导管相关感染:潜在作用
  • 批准号:
    7719251
  • 财政年份:
    2008
  • 资助金额:
    $ 72.04万
  • 项目类别:
CLINICAL TRIAL: NOVEL THERAPY FOR RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS
临床试验:治疗难治性局灶节段性肾小球硬化症的新疗法
  • 批准号:
    7719255
  • 财政年份:
    2008
  • 资助金额:
    $ 72.04万
  • 项目类别:
CLINICAL TRIAL: A PILOT STUDY OF MYCOPHENOLATE MOFETIL IN CONGENITAL UROPATHIES
临床试验:吗替麦酚酯治疗先天性尿路病的试点研究
  • 批准号:
    7719241
  • 财政年份:
    2008
  • 资助金额:
    $ 72.04万
  • 项目类别:
NOVEL THERAPY FOR RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS
抵抗性局灶节段性肾小球硬化症的新疗法
  • 批准号:
    7608248
  • 财政年份:
    2007
  • 资助金额:
    $ 72.04万
  • 项目类别:
A PILOT STUDY OF MYCOPHENOLATE MOFETIL IN CONGENITAL UROPATHIES
吗替麦酚酯治疗先天性尿路病的初步研究
  • 批准号:
    7608227
  • 财政年份:
    2007
  • 资助金额:
    $ 72.04万
  • 项目类别:
NOVEL THERAPY FOR RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
抵抗性局灶节段性肾小球硬化症 (FSGS) 的新疗法
  • 批准号:
    7377133
  • 财政年份:
    2006
  • 资助金额:
    $ 72.04万
  • 项目类别:
CATHETER-RELATED INFECTIONS IN PEDIATRIC DIALYSIS PATIENTS: POTENTIAL ROLE OF
小儿透析患者导管相关感染:潜在作用
  • 批准号:
    7377123
  • 财政年份:
    2006
  • 资助金额:
    $ 72.04万
  • 项目类别:

相似国自然基金

胞浆脱氧鸟苷激酶介导巨噬细胞炎症的兴起与消亡调控NAFLD的进展与转归
  • 批准号:
    81872916
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
基于核酸适配体-纳米胶束的荧光多标记生物传感器检测8-羟基-2'-脱氧鸟苷
  • 批准号:
    21507020
  • 批准年份:
    2015
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
乙型肝炎病毒X蛋白促进8-OHdG介导的致肝细胞DNA突变作用及机制
  • 批准号:
    81572007
  • 批准年份:
    2015
  • 资助金额:
    75.0 万元
  • 项目类别:
    面上项目
孕妇对环境内分泌干扰物的暴露、来源解析及健康风险评价
  • 批准号:
    21577050
  • 批准年份:
    2015
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
电喷雾解吸/萃取电离质谱快速检测尿中羟基多环芳烃研究
  • 批准号:
    21107066
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10445341
  • 财政年份:
    2020
  • 资助金额:
    $ 72.04万
  • 项目类别:
Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10659018
  • 财政年份:
    2020
  • 资助金额:
    $ 72.04万
  • 项目类别:
Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10256661
  • 财政年份:
    2020
  • 资助金额:
    $ 72.04万
  • 项目类别:
Mitochondriopathy of Chronically Ischemic Muscle
慢性缺血性肌肉线粒体病
  • 批准号:
    7367010
  • 财政年份:
    2005
  • 资助金额:
    $ 72.04万
  • 项目类别:
Mitochondriopathy of Chronically Ischemic Muscle
慢性缺血性肌肉线粒体病
  • 批准号:
    7193483
  • 财政年份:
    2005
  • 资助金额:
    $ 72.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了